farglitazar has been researched along with drf 2725 in 1 studies
| Studies (farglitazar) | Trials (farglitazar) | Recent Studies (post-2010) (farglitazar) | Studies (drf 2725) | Trials (drf 2725) | Recent Studies (post-2010) (drf 2725) |
|---|---|---|---|---|---|
| 35 | 3 | 5 | 41 | 3 | 4 |
| Protein | Taxonomy | farglitazar (IC50) | drf 2725 (IC50) |
|---|---|---|---|
| Chain A, peroxisome proliferator activated receptor gamma | Homo sapiens (human) | 0.092 | |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.092 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.98 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaya, T; Sheu, SH; Vajda, S; Waxman, DJ | 1 |
1 other study(ies) available for farglitazar and drf 2725
| Article | Year |
|---|---|
Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.
Topics: Alkanesulfonates; Binding Sites; Cinnamates; Computational Biology; Humans; Ligands; Oxazines; Oxazoles; Phenylpropionates; PPAR gamma; Protein Binding; Protein Conformation; Protein Interaction Mapping; Protein Structure, Tertiary; Rosiglitazone; Solvents; Thiazoles; Thiazolidinediones; Thiazolidines; Tyrosine | 2005 |